Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.

"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.

Zhitong FinanceOct 28 21:30 ET

Zhito Hong Kong shareholder equity disclosure | October 28th

Hong Kong Shareholder Equity Disclosure | October 28th

Zhitong FinanceOct 27 20:05 ET

There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.

Cumulative dividends exceed 0.3 billion in 4 years.

Gelonghui FinanceOct 8 22:04 ET

BIOHEART-B: 2024 INTERIM REPORT

HKEXSep 26 05:34 ET · Announcements

Shanghai Bio-heart Biological Technology Shrinks H1 Loss

MT NewswiresAug 20 04:50 ET

Bai Xin An -B (02185) announced its interim performance. The loss attributable to the parent company's owners was 25.83 million yuan, with a year-on-year narrowing of 70%.

Baixinan-B (02185) announced its mid-term performance in 2024, with R&D spending of approximately RMB 21.8 million (adjusted for inflation). ...

Zhitong FinanceAug 19 09:53 ET